Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lieberman

Showing results (421-430 of 1,485) with videos related to

Pageof 149
Sort By:
Molecular Psychiatry|April 17, 2008
Antipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathwayR R Girgis, J A Javitch, J A Lieberman
The Western Journal of Medicine|March 1, 1984
Ergonovine-provoked esophageal spasm during coronary angiographyD A Lieberman, J W Jendrzejewski, J H McAnulty
Chest|August 1, 1983
Sleep apnea syndrome treated by repair of deviated nasal septumD Heimer, S M Scharf, A Lieberman, et al.
Advances in Biochemical Psychopharmacology|January 1, 1980
The affinities of ergot compounds for dopamine agonist and dopamine antagonist receptor sitesM Goldstein, J Y Lew, A Sauter, et al.
JAMA Psychiatry|April 11, 2019
Are Placebo-Controlled, Relapse Prevention Trials in Schizophrenia Research Still Necessary or Ethical?Ryan E Lawrence, Paul S Appelbaum, Jeffrey A Lieberman
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 5, 1997
Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticityJ A Lieberman, B B Sheitman, B J Kinon
Digestive Diseases and Sciences|September 1, 1983
Colonic varices due to intestinal cavernous hemangiomasD A Lieberman, W W Krippaehne, C S Melnyk
Endocrinology and Metabolism Clinics of North America|September 1, 1992
Rheumatologic and skeletal changes in acromegalyS A Lieberman, A G Björkengren, A R Hoffman
Brain Research. Brain Research Reviews|April 21, 1999
An integrated view of pathophysiological models of schizophreniaG E Duncan, B B Sheitman, J A Lieberman
Psychopharmacology Bulletin|January 1, 1995
Do white-cell count spikes predict agranulocytosis in clozapine recipients?J M Alvir, J A Lieberman, A Z Safferman
Pageof 149

Showing results (421-430 of 1,485) with videos related to

Sort By:
Pageof 149
Molecular Psychiatry|April 17, 2008
Antipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathwayR R Girgis, J A Javitch, J A Lieberman
The Western Journal of Medicine|March 1, 1984
Ergonovine-provoked esophageal spasm during coronary angiographyD A Lieberman, J W Jendrzejewski, J H McAnulty
Chest|August 1, 1983
Sleep apnea syndrome treated by repair of deviated nasal septumD Heimer, S M Scharf, A Lieberman, et al.
Advances in Biochemical Psychopharmacology|January 1, 1980
The affinities of ergot compounds for dopamine agonist and dopamine antagonist receptor sitesM Goldstein, J Y Lew, A Sauter, et al.
JAMA Psychiatry|April 11, 2019
Are Placebo-Controlled, Relapse Prevention Trials in Schizophrenia Research Still Necessary or Ethical?Ryan E Lawrence, Paul S Appelbaum, Jeffrey A Lieberman
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 5, 1997
Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticityJ A Lieberman, B B Sheitman, B J Kinon
Digestive Diseases and Sciences|September 1, 1983
Colonic varices due to intestinal cavernous hemangiomasD A Lieberman, W W Krippaehne, C S Melnyk
Endocrinology and Metabolism Clinics of North America|September 1, 1992
Rheumatologic and skeletal changes in acromegalyS A Lieberman, A G Björkengren, A R Hoffman
Brain Research. Brain Research Reviews|April 21, 1999
An integrated view of pathophysiological models of schizophreniaG E Duncan, B B Sheitman, J A Lieberman
Psychopharmacology Bulletin|January 1, 1995
Do white-cell count spikes predict agranulocytosis in clozapine recipients?J M Alvir, J A Lieberman, A Z Safferman
Pageof 149